MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Positive DA-1726 16-Week Phase 1 Part 3 Interim Data Support Planned Phase 2 Development in MetALD and ALD Appointed Sarah Browne, M.D., as Chief Medical Officer to Help Lead the Next Stage of Clinical Development for DA-1726 and…
1 source(s) traitant du même sujet, rubrique Presse & Tech.